OB/GYN Clinical Alert
RSSArticles
-
Special Feature: Current Management of Rh and Kell Sensitization
-
Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers
-
Clinical Briefs in Primary Care Supplement
-
Empiric Vaginal Metronidazole in the Management of the ASCUS Pap Smear
-
Intraperitoneal Chemotherapy for Ovarian Carcinoma
-
MORE Data, MORE Questions
-
Pharmacology Watch: GlaxoSmithKline Withdraws Lymerix: Company ‘Cuts Losses’ on Controversial Lyme Disease Vaccine
-
Postmenopausal Hormone Therapy and the Risk of Breast Cancer
-
Do Patients Need Routine Pelvic Exams?
A review of the published literature finds no value to the routine screening pelvic examination in asymptomatic non-pregnant women. -
AMH: Marker of Ovarian Reserve and More
Serum anti-Mullerian hormone (AMH) has been well-established as an accurate marker of ovarian reserve. It is solely produced in the human ovary by the granulosa cells.